GC Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$65M
- Investors
-
16
GC Therapeutics General Information
Description
Developer of a genome-wide cell programming platform designed to convert stem cells into multiple cell types. The company utilizes synthetic biology and proprietary differentiation technology to program cell fate and enable scalable cell production, enabling healthcare providers to access cell therapies with improved manufacturing efficiency.
Contact Information
Website
www.gc-tx.comCorporate Office
- 610 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 610 Main Street
- Cambridge, MA 02139
- United States
GC Therapeutics Timeline
GC Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 19-Sep-2024 | $65M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | 10-Apr-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 09-Feb-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 24-Sep-2019 | Completed | Generating Revenue | |||
| 3. Grant | 02-May-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-May-2019 | Completed | Startup |
GC Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GC Therapeutics Patents
GC Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025147551-A1 | Methods and compositions for stem cell differentiation | Inactive | 03-Jan-2024 | ||
| EP-4828957-A1 | Methods and compositions for stem cell differentiation | Pending | 20-Dec-2023 | ||
| WO-2025137379-A1 | Methods and compositions for stem cell differentiation | Inactive | 20-Dec-2023 | ||
| EP-4547822-A2 | Methods and compositions for stem cell differentiation | Pending | 30-Jun-2022 | ||
| EP-4547822-A4 | Methods and compositions for stem cell differentiation | Pending | 30-Jun-2022 | C12N5/0634 |
GC Therapeutics Signals
GC Therapeutics Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alumni Ventures | Venture Capital | Minority | ||
| Calm Ventures | Venture Capital | Minority | ||
| Cercano Management | PE/Buyout | Minority | ||
| Cormorant Asset Management | PE/Buyout | Minority | ||
| Gaingels | Venture Capital | Minority |
GC Therapeutics FAQs
-
When was GC Therapeutics founded?
GC Therapeutics was founded in 2019.
-
Where is GC Therapeutics headquartered?
GC Therapeutics is headquartered in Cambridge, MA.
-
What is the size of GC Therapeutics?
GC Therapeutics has 45 total employees.
-
What industry is GC Therapeutics in?
GC Therapeutics’s primary industry is Biotechnology.
-
Is GC Therapeutics a private or public company?
GC Therapeutics is a Private company.
-
What is the current valuation of GC Therapeutics?
The current valuation of GC Therapeutics is .
-
What is GC Therapeutics’s current revenue?
The current revenue for GC Therapeutics is .
-
How much funding has GC Therapeutics raised over time?
GC Therapeutics has raised $74.7M.
-
Who are GC Therapeutics’s investors?
Alumni Ventures, Calm Ventures, Cercano Management, Cormorant Asset Management, and Gaingels are 5 of 16 investors who have invested in GC Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process